Related posts
Aphria gives the TSX a nice buzz while U.S. banks report mixed earningsOne Year of Cannabis Investing: Happy Birthday, Mary Jane!Oil wobbles, weed sinks, the Fed cuts?This summary was created by AI, based on 3 opinions in the last 12 months.
Horizon’s Medical Marijuana (HMMJ-T) has faced significant challenges in the cannabis sector, which has seen negative returns for the past five years. This period has led to the consolidation of the industry, effectively eliminating weaker players and creating potential long-term investment opportunities. Experts suggest waiting until February to assess whether the selling pressure has eased after tax-loss selling at year-end. The general advice is to approach investments in this industry with caution, especially considering the volatility and risks associated with individual stocks versus ETFs. While there is potential for recovery, investing should be approached carefully, with some experts advocating for holding the ETF to minimize company-specific risks.
He's not the best person to talk to, because he doesn't believe in them. He's seen too many people lose money. It's been a rough ride. Be really careful. At some point you're not investing, you're just gambling. As well, the reverse stock splits get hidden in the ETF price.
Just because it's been reclassified, doesn't mean it's going to get widespread rollout in the US. How far away is that, and will some of these companies even be around at the rate they're burning cash?
If you're determined, own the ETF instead of individual stocks. That way, you have sector-specific risk, but not company-specific risk. If you want a home run, pick one and pray that it works out.
This asset class has been down for 5 years during a long period of investor apathy. But when an asset class has been down for longer than 3 years, you start to consider it. HMMJ has US exposure where there is growing public support for legalizing canopy. Maybe start with a small position. This is a volatile sector.
HMMJ vs. HMUS. A monstrous opportunity, but you're going to suffer volatility. Go slow, get in over time, and keep it to a smaller proportion of your portfolio. Market weighted. The US exposure is to companies operating legally, and there can't be any recreational use. With HMUS, you're tapping into a bigger market. For example, Charlotte's Web is planning to sell CBD infused products through Kroeger. This scale dwarfs the whole Canadian market. Valuations are high because of the growth potential. If you're a marijuana investing aficionado, you'd want to own both.
Horizon's Medical Marijuana is a Canadian stock, trading under the symbol HMMJ-T on the Toronto Stock Exchange (HMMJ-CT). It is usually referred to as TSX:HMMJ or HMMJ-T
In the last year, 2 stock analysts published opinions about HMMJ-T. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Horizon's Medical Marijuana.
Horizon's Medical Marijuana was recommended as a Top Pick by on . Read the latest stock experts ratings for Horizon's Medical Marijuana.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Horizon's Medical Marijuana In the last year. It is a trending stock that is worth watching.
On 2025-04-15, Horizon's Medical Marijuana (HMMJ-T) stock closed at a price of $6.19.
The cannabis space has had time to consolidate, taking out the weaker players. The sector has been down for 5 years. There's long-term opportunity in this space following persistent negative returns. Consolidation clears the decks, though. Wait till February to see if selling has abated, following tax-loss selling at the end of last year, and maybe there will be a rebound. This is a small position in your portfolio overall.